1305 Participants Needed

Cognitive Training for Mild Cognitive Impairment

Recruiting at 4 trial locations
JE
JS
AO
GS
AW
MC
Overseen ByMarlayna Cromedy
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Older adults at risk for dementia show a variety of cognitive deficits, which can be ameliorated by different cognitive training (CT) exercises. The best combination of CT exercises is unknown. The aim is to discover the most efficacious combination of CT exercises as compared to cognitive stimulation (which will serve as a stringent, active control) to modify the functional trajectories of older adults' with MCI, who are at high risk for dementia. The primary objective of the U01 phase was to design and pilot-test an adaptive, randomized clinical trial (RCT) of cognitive training (CT) combinations aimed to enhance performance of instrumental activities of daily living (IADL) among persons with mild cognitive impairment (MCI). In the R01 phase, the objective is to identify the best combination of CT exercises to delay dementia onset among persons with MCI. The longitudinal endpoint goal is reducing incident dementia. The primary aim of the study is to determine which CT combination has the best probability to delay dementia by producing the largest IADL improvements. The study further aims to explore neuroimaging and novel blood-based biomarkers.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are taking medications typically prescribed for dementia, like Namenda or Aricept, your dose must have been stable for at least 30 days before joining the study.

What data supports the effectiveness of the treatment Cognitive Training for Mild Cognitive Impairment?

Research shows that computerized cognitive training can improve cognitive function in older adults with mild cognitive impairment, although the evidence is still limited. It has been used successfully in neurological rehabilitation, particularly for attention deficits, and is considered a valuable tool when integrated into a broader therapeutic plan.12345

Is cognitive training safe for people with mild cognitive impairment?

Research indicates that computerized cognitive training is generally safe for older adults, including those with mild cognitive impairment.36789

How is Cognitive Training different from other treatments for mild cognitive impairment?

Cognitive Training is unique because it uses computer-based exercises to target specific brain functions and improve cognitive abilities through neuroplasticity (the brain's ability to reorganize itself). Unlike medications, which have generally not been successful for mild cognitive impairment, this approach leverages the brain's natural capacity to adapt and change.123510

Research Team

JE

Jerri Edwards, PhD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Adults aged 55-89 with mild cognitive impairment (MCI) are eligible for this trial. They must have a certain score on a cognitive assessment, stable medication use, and changes in cognitive function from their baseline. Participants need to be able to see, hear, and use a computer. Those with severe dementia or other major health issues that affect cognition or study participation are excluded.

Inclusion Criteria

I am between 55 and 89 years old.
I understand and can follow the study's procedures.
I can hear normal speech in at least one ear.
See 7 more

Exclusion Criteria

Your score on the Geriatric Depression short scale is higher than 5 out of 15. If you have a mood disorder that is controlled with treatment and your score is lower than 6 out of 15, you are not excluded.
You cannot have an MRI because you have a pacemaker, metal implants in your body, or feel very scared in small spaces.
I have been diagnosed with dementia.
See 15 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cognitive training exercises aimed at improving instrumental activities of daily living (IADL) and delaying dementia onset

16 weeks
2-3 visits per week (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments of dementia incidence and cognitive function

6 months to 2 years
Periodic follow-up visits

Treatment Details

Interventions

  • Cognitive Training
  • Computerized Cognitive Stimulation
Trial OverviewThe trial is testing different combinations of cognitive training exercises against computerized cognitive stimulation to improve daily living activities and delay the onset of dementia in older adults at risk. It includes neuroimaging and blood biomarker analysis to identify the most effective CT combination.
Participant Groups
5Treatment groups
Experimental Treatment
Active Control
Group I: CTacExperimental Treatment1 Intervention
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Group II: CTabcExperimental Treatment1 Intervention
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Group III: CTabExperimental Treatment1 Intervention
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Group IV: CTaExperimental Treatment1 Intervention
Participants will complete computerized cognitive training. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Group V: Computerized Cognitive StimulationActive Control1 Intervention
Participants will complete cognitively-stimulating computer activities. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

University of South Florida

Lead Sponsor

Trials
433
Recruited
198,000+

University of Florida

Collaborator

Trials
1,428
Recruited
987,000+

University of California, San Francisco

Collaborator

Trials
2,636
Recruited
19,080,000+

University of Minnesota

Collaborator

Trials
1,459
Recruited
1,623,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Clemson University

Collaborator

Trials
38
Recruited
8,200+

Findings from Research

Home-based Computerized Cognitive Training (CCT) tailored to individual needs significantly improved cognitive functions such as memory and learning in older adults with mild cognitive impairment (MCI) and mood-related neuropsychiatric symptoms (MrNPS) over an 8-12 week period.
Participants in the CCT group not only showed enhanced cognitive performance but also reported improved mood and reduced caregiver burden compared to those in the active control group, indicating broader benefits beyond just cognitive outcomes.
Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial.Bahar-Fuchs, A., Webb, S., Bartsch, L., et al.[2022]
Computer-assisted cognitive training has been shown to be an effective tool in neurological rehabilitation, particularly for patients with attention deficits, as it allows for precise stimulus representation and reaction time measures.
This type of training is most beneficial when integrated into a comprehensive therapeutic framework, enhancing the overall rehabilitation process and ensuring sufficient therapeutic intensity.
[Computer-assisted neuropsychological training in neurological rehabilitation].Reuter, BM., Schรถnle, PW.[2006]
Computerized cognitive training (CCT) has been shown to provide a significant but small improvement in global cognitive function in patients with mild cognitive impairment (MCI), based on a systematic review of 18 studies involving 1059 participants.
While CCT also led to marginal improvements in specific cognitive domains, the overall effect size was modest, indicating the need for larger and longer-term studies to better understand its efficacy and potential recommendations for clinical use.
Effectiveness of Computerized Cognitive Training in Delaying Cognitive Function Decline in People With Mild Cognitive Impairment: Systematic Review and Meta-analysis.Li, R., Geng, J., Yang, R., et al.[2022]

References

Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial. [2022]
[Computer-assisted neuropsychological training in neurological rehabilitation]. [2006]
Effectiveness of Computerized Cognitive Training in Delaying Cognitive Function Decline in People With Mild Cognitive Impairment: Systematic Review and Meta-analysis. [2022]
Qualitative Analysis of the Cognition and Flow (CoGFlowS) Study: An Individualized Approach to Cognitive Training for Dementia Is Needed. [2021]
Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial. [2020]
Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. [2022]
Cognitive training based on functional near-infrared spectroscopy neurofeedback for the elderly with mild cognitive impairment: a preliminary study. [2023]
Effects of Home-Based Computerized Cognitive Training in Community-Dwelling Adults With Mild Cognitive Impairment. [2023]
The Effects of Cognitive Training in Healthy Community Residing Thai Elderly: A Randomized Controlled Trial. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
A Comparative Single-Blind Randomized Controlled Trial With Language Training in People With Mild Cognitive Impairment. [2020]